The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Proportion of Participants Who Scored Above the Midpoint on the Client Satisfaction Scale (CSQ)
Timeframe: Post-Test (6 Weeks)
Proportion of Participants Who Scored Above the Midpoint on Each Subscale of the Credibility and Expectancy Questionnaire (CEQ)
Timeframe: Baseline (0 Weeks)
Feasibility of recruitment
Timeframe: Baseline (0 Weeks)
Rate at which program was accepted, measured by number of completed program sessions
Timeframe: Post-Test (6 Weeks)
Feasibility of Assessments at Baseline
Timeframe: Baseline (0 Weeks)
Feasibility of Assessments at Post-Test
Timeframe: Post-Test (6 Weeks)
Feasibility of Assessments at Follow-Up
Timeframe: Follow-Up (30 Weeks)
Intervention fidelity
Timeframe: Collected during intervention, an average of 6 weeks
Proportion of participants who report symptom improvements as measured by the Global Rating of Change (GRoC) Scale
Timeframe: Post-Test (6 Weeks)
Adverse Events
Timeframe: Collected during intervention, an average of 6 weeks